Concentra Group Holdings Parent, Inc. (CON) Stock
Key stats
- Market cap
- $5.46B
- Price / Earnings ratio
- 25.0x
- EPS (TTM)
- $1.69
- Volume
- Loading
- 52-week high
- $44.22
- 52-week low
- $18.96
- Dividend yield
- 0.57%
- Dividend amount (latest)
- $0.06
Source: third-party data provider, as of November 13, 2026
Compare with CON
Recent news

CON vs. MEDP: Which Stock Is the Better Value Option?
CON vs. MEDP: Which Stock Is the Better Value Option?
CON

Is Concentra Group Holdings Parent, Inc. (CON) Stock Outpacing Its Medical Peers This Year?
Is Concentra Group Holdings Parent, Inc. (CON) Stock Outpacing Its Medical Peers This Year?
CON

Concentra Group Holdings Parent, Inc. (CON) Hits Fresh High: Is There Still Room to Run?
Concentra Group Holdings Parent, Inc. (CON) Hits Fresh High: Is There Still Room to Run?
CON

Concentra Expands Occupational Health Access in Greater Washington D.C. Metro with New Arlington Medical Center
Concentra Expands Occupational Health Access in Greater Washington D.C. Metro with New Arlington Medical Center
CON
News tone: automated (AI) classification of the article's content, not a price prediction.
Technical indicators
- RSI 14
- 70.75
- MACD 12/26/9
- 1.59
- EMA 9 of MACD
- 1.45
- MACD histogram
- 0.14
- SMA 50
- $37.53
- Price above SMA 50
- EMA 50
- $38.13
- Price above EMA 50
- SMA 200
- $29.31
- Price above SMA 200
- EMA 200
- $30.08
- Price above EMA 200
Calculated by Gotrade from daily closing prices, as of November 11, 2026. Technical data, not a recommendation.
Analyst ratings
Analyst consensus: Buy
Based on 4 analyst ratings
Third-party analyst opinion, not a recommendation from Gotrade.
Financials
Performance
Debt & Balance Sheet
Revenue to Profit
2025Earnings
No data available
Source: third-party data provider
Latest news

CON vs. MEDP: Which Stock Is the Better Value Option?
CON vs. MEDP: Which Stock Is the Better Value Option?
CON

Is Concentra Group Holdings Parent, Inc. (CON) Stock Outpacing Its Medical Peers This Year?
Is Concentra Group Holdings Parent, Inc. (CON) Stock Outpacing Its Medical Peers This Year?
CON

Concentra Group Holdings Parent, Inc. (CON) Hits Fresh High: Is There Still Room to Run?
Concentra Group Holdings Parent, Inc. (CON) Hits Fresh High: Is There Still Room to Run?
CON

Concentra Expands Occupational Health Access in Greater Washington D.C. Metro with New Arlington Medical Center
Concentra Expands Occupational Health Access in Greater Washington D.C. Metro with New Arlington Medical Center
CON

CON vs. MEDP: Which Stock Should Value Investors Buy Now?
CON vs. MEDP: Which Stock Should Value Investors Buy Now?
CON

Concentra to Announce Third Quarter 2026 Results on Thursday, November 5, 2026
Concentra to Announce Third Quarter 2026 Results on Thursday, November 5, 2026
CON

Concentra Group Holdings Parent, Inc. (CON) Hit a 52 Week High, Can the Run Continue?
Concentra Group Holdings Parent, Inc. (CON) Hit a 52 Week High, Can the Run Continue?
CON

Why Concentra's Quiet Healthcare Business Keeps Winning
Why Concentra's Quiet Healthcare Business Keeps Winning
CON

CON or MEDP: Which Is the Better Value Stock Right Now?
CON or MEDP: Which Is the Better Value Stock Right Now?
CON

Concentra Group Holdings Parent, Inc. (CON) Hits Fresh High: Is There Still Room to Run?
Concentra Group Holdings Parent, Inc. (CON) Hits Fresh High: Is There Still Room to Run?
CON
News tone: automated (AI) classification of the article's content, not a price prediction.
About Concentra Group Holdings Parent, Inc.
No description available.
Key Executives
| Name | Title | Year Born |
|---|---|---|
| Mr. William Keith Newton | CEO & Director | 1963 |
| Mr. Matthew T. DiCanio M.B.A. | President & CFO | 1983 |
| Mr. John A. deLorimier | Executive VP and Chief Information & Technology Officer | 1960 |
| Mr. Timothy F. Ryan | Executive VP & Chief Legal Counsel | 1961 |
| Dr. John R. Anderson DO, FACOEM | Executive VP & Chief Medical Officer | 1950 |
| Ms. Su Zan Nelson CPA | Executive VP & Chief Accounting Officer | 1964 |
| Mr. Bill Chapman | Vice President of Strategy & Investor Relations | — |
| Mr. Thomas A. Devasia | Executive VP and Chief Marketing & Innovation Officer | 1970 |
| Ms. Danielle Kendall | Executive VP & Chief People Officer | 1969 |
| Mr. Giovanni Gallara | Executive VP & Chief Clinical Services Officer | 1975 |
Fundamentals
Valuation
Profitability
Trading
Dividend
Source: third-party data provider, as of November 13, 2026
Technical indicators
- RSI 14
- 70.75
- MACD 12/26/9
- 1.59
- EMA 9 of MACD
- 1.45
- MACD histogram
- 0.14
- SMA 50
- $37.53
- Price above SMA 50
- EMA 50
- $38.13
- Price above EMA 50
- SMA 200
- $29.31
- Price above SMA 200
- EMA 200
- $30.08
- Price above EMA 200
Calculated by Gotrade from daily closing prices, as of November 11, 2026. Technical data, not a recommendation.
Analyst views
4 analyst ratings
Third-party analyst opinion, not a recommendation from Gotrade.
- Low
- $43.00
- Average
- $48.25
- High
- $51.00
Seasonality
Monthly price change (%)| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024 | +3.7 | +7.9 | -6.3 | -6.8 | +8.7 | -8.1 | ||||||
| 2025 | +20.8 | -2.7 | -3.0 | -1.2 | +0.5 | -4.3 | -4.2 | +22.2 | -11.8 | -4.4 | +4.5 | -4.2 |
| 2026 | +14.3 | +8.2 | -9.6 | +5.8 | +10.4 | +17.8 | +2.9 | +6.4 | +1.6 | +15.5 | +7.7 |



